Vimarsana
Biggest News Aggregation in the World

Page 31 - Sny News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sny Today - Breaking & Trending Today

Sanofi Hemophilia Drug Deemed Safe, Effective in Phase 3 Trial - Vimarsana News

Sanofi Hemophilia Drug Deemed Safe, Effective in Phase 3 Trial

By David Sachs Sanofi said late Sunday that newly released Phase 3 data on its hemophilia treatment, Altuviiio, confirmed the drug's effectiveness and...

CDC Advisors Give Tepid Endorsement of GSK, Pfizer RSV Vaccines. What to Know. - Vimarsana News

CDC Advisors Give Tepid Endorsement of GSK, Pfizer RSV Vaccines. What to Know.

A key committee backed a policy saying adults 65 and older "may receive" the shots, rather than one saying the injections "are recommended."

Mets broadcast suffers technical issues during game against Astros - Vimarsana News

Mets broadcast suffers technical issues during game against Astros

Likely due to extreme temperatures in Houston -- which reached triple digits Wednesday -- SNY's broadcast experienced technical difficulties Wednesday, prompting play-by-play voice Gary Cohen to issue an apology to loyal viewers sitting through the game.

Source: nypost.com
Organic compost bills to mandate collection - Vimarsana News

Organic compost bills to mandate collection

The City Council overwhelmingly passed a package of sanitation-related bills on June 8, including legislation that would mandate that New Yorkers separate food waste from their trash to be composted

Source: qchron.com
RS Group plc (LON:RS1) Receives Average Recommendation of "Hold" from Analysts - Vimarsana News

RS Group plc (LON:RS1) Receives Average Recommendation of "Hold" from Analysts

Shares of Sanofi (NASDAQ:SNY – Get Rating) have been given an average recommendation of “Moderate Buy” by the twelve research firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the […]